Find policies, billing codes, payers, states, and providers
CPT 95857: Edrophonium (Tensilon) Test for Myasthenia Gravis
CPT code 95857 designates an intravenous edrophonium (Tensilon) or other cholinesterase inhibitor test used to support the clinical diagnosis of myasthenia gravis by demonstrating transient improvement in muscle strength. The procedure is a focused diagnostic pharmacologic test performed in outpatient or hospital outpatient settings and has relevance for neurologists, emergency clinicians, and diagnostic service lines. Nationally, accurate coding of this test affects diagnostic pathways for patients with suspected neuromuscular junction disorders and informs utilization and coverage discussions.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code and clinical context, typical sites of service, common modifiers and billing considerations (listed separately), and what to expect in terms of documentation and coding descriptors. The publication also highlights benchmarks and policy updates where available and summarizes the role of the test within diagnostic workflows for myasthenia gravis. Data not available in the input for some payer-specific coverage details and associated taxonomies is noted elsewhere in the full publication.
Customize your policy alerts
Sign up for cpt 95857 policy alerts
Get alerted when payer policies referencing 95857 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 95857 describes an intravenous cholinesterase inhibitor test used to evaluate patients suspected of having myasthenia gravis, a neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. During this diagnostic procedure, a provider injects edrophonium (Tensilon) or another cholinesterase inhibitor into a peripheral vein while observing for a transient clinical improvement in muscle strength.
Service type: Diagnostic pharmacologic test
Typical site of service: Outpatient clinic or hospital outpatient department, including neurology clinics or specialized diagnostic centers.